Abstract
Aim: The study aimed to observe and compare the demographic, comorbidities, biomarkers in different categories of diagnosed COVID-19 patients admitted to a COVID dedicated tertiary care hospital in the pic time of the pandemic, 2020, at Dhaka, Bangladesh. Methods: This retrospective study was conducted from May to September 2020 in 720 bed Holy Family Red Crescent Medical College Hospital. Four hundred seventy-three patients included in this study, diagnosed by RT-PCR of the nasopharyngeal swab, were divided into four groups. The mild group includes 254 patients, the moderate group has 82 patients, 38 patents in the severe group, and the critical group who were admitted to ICU, 99 patients. Demographic data, available investigation reports of individual patients, obtained from hospital records manually and compared between all four different categories of patients.
Highlights
Aim: The study aimed to observe and compare the square test for qualitative variables and one-way ANOVA for demographic, comorbidities, biomarkers in different quantitative variables were done by SPSS version 21.0, and all categories of diagnosed COVID-19 patients admitted to a values were two-tailed, with p < .05 considered as statistically
The preliminary observations and outcomes of Methods: This retrospective study was conducted from May to disease severity in the case of COVID-19 included age, the September 2020 in 720 bed Holy Family Red Crescent presence of co-morbid conditions, and changes in 39
The clinical patients, 38 patents in the severe group, and the critical group correlation and management strategy should be adopted with who were admitted to ICU, 99 patients
Summary
This retrospective study was conducted from May to disease severity in the case of COVID-19 included age, the September 2020 in 720 bed Holy Family Red Crescent presence of co-morbid conditions, and changes in 39. Four hundred seventy-three patients hematological, inflammatory, and hepatic biomarkers in the included in this study, diagnosed by RT-PCR of the blood. The mild cough, breathlessness in severe and critical case, whereas group includes 254 patients, the moderate group has 82 anosmia was a common predictor in mild cases. The clinical patients, 38 patents in the severe group, and the critical group correlation and management strategy should be adopted with who were admitted to ICU, 99 patients. From hospital records manually and compared between all four Keywords: COVID-19, biomarkers, co-morbidities, different categories of patients.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
